Healthcare & Life Sciences
Jerini
Germany
acquiredacquired
acquired
Stage
1994
Founded
About
Jerini was a German pharmaceutical company focused on the discovery, development, and commercialization of novel peptide-based drugs. It was acquired by Shire Limited in 2008 for its lead drug, Firazyr, which treated hereditary angioedema.
Explore Jerini's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.